Page last updated: 2024-08-20

nafcillin and moxalactam

nafcillin has been researched along with moxalactam in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19903 (60.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lombardo, F; Obach, RS; Waters, NJ1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Chuah, SK; Dhawan, VK; Maier, MK; Nayyar, M; Thadepalli, H1
Bansal, MB; Chuah, SK; Dhawan, VK; Maier, MK; Nayyar, M; Thadepalli, H1
Alanis, A; Rehm, S; Weinstein, AJ1

Trials

1 trial(s) available for nafcillin and moxalactam

ArticleYear
Comparative efficacy and toxicity of moxalactam and the combination of nafcillin and tobramycin in febrile granulocytopenic patients.
    Cleveland Clinic quarterly, 1983,Winter, Volume: 50, Issue:4

    Topics: Agranulocytosis; Clinical Trials as Topic; Drug Therapy, Combination; Female; Fever; Humans; Infections; Male; Moxalactam; Nafcillin; Prospective Studies; Random Allocation; Tobramycin

1983

Other Studies

4 other study(ies) available for nafcillin and moxalactam

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
In vitro activity of cefmenoxime, cefotaxime, latamoxef, cefazolin, nafcillin and vancomycin against 53 endocarditis and bacteremic strains of Staphylococcus aureus.
    Chemotherapy, 1984, Volume: 30, Issue:5

    Topics: Anti-Bacterial Agents; Cefazolin; Cefmenoxime; Cefotaxime; Endocarditis, Bacterial; Humans; Microbial Sensitivity Tests; Moxalactam; Nafcillin; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin

1984
Newer beta-lactam antibiotics in the treatment of experimental Staphylococcus aureus endocarditis.
    The Journal of antimicrobial chemotherapy, 1984, Volume: 14, Issue:2

    Topics: Animals; Cefmenoxime; Cefotaxime; Endocarditis, Bacterial; Humans; Male; Microbial Sensitivity Tests; Moxalactam; Nafcillin; Rabbits; Staphylococcal Infections

1984